About Omnicare’s Court Supervised Process
Continuing Delivery of Safe and Reliable Pharmacy Services to All Customers
Court-Supervised
Sale Process
Omnicare entered into an asset purchase agreement with GenieRx Holdings LLC, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services, who will serve as the “stalking horse” bidder in Omnicare’s ongoing court-supervised sale process. As part of the process, GenieRx will set the floor for the sale of the Company’s assets, while allowing other interested parties to submit competing bids through April 30. The process will conclude with the highest and best offer, subject to Court approval.
Omnicare is
Operating as Normal
From everyday care to specialized services – Omnicare is operating as normal, so our customers can focus on what matters most: meeting the healthcare needs of their long‑term care residents.
Omnicare continues to focus on helping skilled nursing and assisted living providers navigate the increasing clinical, regulatory, and operational complexity of long‑term care through thoughtful pricing approaches, clinically meaningful programs, service models designed for the realities of long term care, and ongoing engagement with our customers.
Supporting Our
Customers and Prospects
Omnicare has a proud history of providing industry‑leading pharmacy and clinical care solutions to long‑term care providers and residents. As we move through this process, our top priority continues to be providing safe and reliable pharmacy and clinical services.
Care Settings
We Support
As we emerge from restructuring, we are focused on strengthening the areas customers have told us matter most: clinical outcomes, transparency, cost optimization, and resident experience. Our 2026–2027 strategy includes enhancements to pricing, clinical capabilities, service models, and customer engagement — all designed to help you navigate the increasing acuity, regulatory, and financial demands of long-term care.
- Cost-transparent models designed to support financial predictability
- Enhanced clinical programs aligned to CMS Value-Based Purchasing (VBP) measures
- Actionable analytics that support star rating improvement, survey readiness, and demonstrated clinical value
- Clinical programs focused on reducing avoidable hospitalizations transitions of care and supporting aging-in-place
- Streamlined delivery, communication, and billing experiences designed to reduce operational friction
- Reducing administrative burden for ALFs by streamlining pharmacy coordination: supporting resident choice while minimizing the operational complexity placed on facility staff
Sales Process FAQs
- When Omnicare initiated Chapter 11 proceedings, we said that as part of this process we would consider a sale strategy as an option for our business.
- This is an important step in that process, and we are confident that we are taking the right steps to advance our goal of ensuring the continued delivery of safe and reliable pharmacy services.
- As we move through the court-supervised process, we remain fully committed to delivering safe and reliable pharmacy and clinical services to our customers and residents.
- A stalking horse bidder is an initial buyer that enters into an asset purchase agreement as part of a court-supervised sale process.
- The agreement sets a minimum, or “floor,” value for the company’s assets, while allowing other qualified bidders to submit higher or otherwise better offers.
- This is just one step in the process.
- The deadline for interested parties to submit competing bids is April 30, 2026.
- If qualified bids are received, an auction is expected to be held on May 5, 2026.
- A hearing to approve the sale to the winning bidder will be scheduled shortly thereafter, subject to the availability of the Court.
- We are pleased to have reached an agreement with GenieRx Holdings LLC, a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services, who has agreed to acquire all of our assets.
- As part of this process, GenieRx will serve as the “stalking horse” bidder, establishing a baseline for the sale of our business while allowing other interested parties to submit competing bids to attract the highest and best offer for our business.
- This is an important first step in advancing our goal of ensuring the continued delivery of safe and reliable pharmacy services.
- Throughout this process, we remain focused on delivering value to long-term care providers in the areas that matter most to them.
- Customers should continue to expect no changes in how we support them or their residents.
- We remain fully committed to providing customers and residents with safe and reliable pharmacy and clinical services.
- From everyday care to specialized services – we are operating as normal, so you can focus on what matters most: meeting the pharmacy needs of your long-term care residents.
- We continue to pay vendors and suppliers in full under normal terms for goods and services provided after the filing date.
- We have access to sufficient cash to conduct normal operations during this process, including paying our vendors.
- We rely on the cooperation of all of our vendors, as they play a critical role in enabling us to provide safe and reliable pharmacy and clinical services for our customers and residents as we move through this process.
Learn More
Additional information regarding Omnicare’s court‑supervised process is available at: